Clinical Trial Update: How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding insulin glargine and exenatide, alongside oral diabetes medications, improves blood sugar control and affects weight in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)
• Lantus (insulin glargine)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2013-02-06